產(chǎn)品詳情
簡單介紹:
Caspase-13InhibitorLEED-FMK
詳情介紹:
Purpose | A caspase-13 inhibitor |
Sequence | Z-Leu-Glu(OMe)-Glu(OMe)-Asp(OMe)-FMK |
Characteristics |
PubChem CID: 44135223 A synthetic peptide inhibitor that inhibits caspase-13 and related caspase activity. FMK inhibitors are irreversible and non-toxic, and can be used in both in vivo and in vitro studies. The inhibitor is designed as a methyl ester to facilitate cell permeability. (CAUTION: If the intended use is on purified or recombinant enzymes, esterase should be added to generate free carboxyl groups). |
Purity | > 95?% by HPLC |
Chemical Name | Z-LEED-FMK, Z-LEED-fluoromethylketone, Caspase-13 Inhibitor (fluoromethylketone) |
Formula | C??H??FN?O?? |
Permeability | Cell-permeable |
Solubility | In DMSO (10 mM) |
Molecular Weight | 696.7 g/mol |
Application Notes | We recommend using 1000-5000X dilutions for inhibiting caspase-13 and related caspase activity (e.g., Add 1 μL to 1-5 mL of culture medium). The optimal doses may vary among different cells and culture conditions. The inhibitor is designed as a methyl ester to facilitate cell permeability. |
Restrictions | For Research Use only |
Format | Liquid |
Concentration | 10 mM |
Handling Advice | Protect from light and moisture |
Storage | -20 °C |
Expiry Date | 12 months |
Product cited in: |
Bian, Sun, Silver, Ho, Marchionni, Caggiano, Stone, Amende, Hampton, Morgan, Yan: "Neuregulin-1 attenuated doxorubicin-induced decrease in cardiac troponins." in: American journal of physiology. Heart and circulatory physiology, Vol. 297, Issue 6, pp. H1974-83, 2009 (PubMed).
|